Medical News Summary: FDA approves new pulmonary arterial hypertension drug


About: FDA approves new pulmonary arterial hypertension drug
Date: 29 December 2004
Source: Forbes
Medical News Summary (summary of medical news story as reported by Forbes): CoTherix Inc. has had itís new drug Ventavis approved by the FDA for use as an inhalant treatment for pulmonary arterial hypertension in patients with heart failure symptoms. Roughly 50,000 US people are believed to have the condition but only 15,000 have been diagnosed and are being treated.
Related Disease Topics: Pulmonary arterial hypertension, Heart failure

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
  • Diagnosis
  • Diagnosis and pulmonary arterial hypertension
  • Diagnosis and heart failure
  • Undiagnosed
  • Undiagnosed and pulmonary arterial hypertension
  • Undiagnosed and heart failure
  • Medication
  • Medication and pulmonary arterial hypertension
  • medication and heart failure

Medical Tools & Articles:

Next articles:

Medical Articles:
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise